StockGuru Shines its Spotlight on Applied DNA Sciences, Inc. (OTCBB: APDN) Upon Announcement that It Will Be a Sponsor of 2011 International Law Enforcement IP Crime Conference — September 21, 2011

StockGuru Shines its Spotlight on Applied DNA Sciences, Inc. (OTCBB: APDN) Upon Announcement that It Will Be a Sponsor of 2011 International Law Enforcement IP Crime Conference — September 21, 2011

(Dallas, TX. – September 21, 2011) StockGuru Shines its Spotlight on Applied DNA Sciences, Inc. (OTCBB: APDN), a provider of DNA-based anti-counterfeiting technology and product authentication solutions, announced yesterday that it will be a Silver Sponsor of a major Intellectual Property Crime conference, to be held in Madrid on September 20-22. In recent years, the conference has drawn some of the largest, most effective anti-counterfeiting and anti-piracy security organizations globally.  The Company closed on September 20, 2011, at $0.06, trading in a fifty-two week range of $0.10 – 0.04.

The International Law Enforcement IP Crime Conference is co-hosted by Interpol, Europol and the Cuerpo Nacional de Policia in partnership with Underwriters Laboratories (UL). The conference has traditionally highlighted the truly global and rising scope of counterfeiting, piracy, and illicit trade.

APDN has recently taken its place on the world stage, having become a rising force in security and anti-counterfeiting world-wide. The company protects more than a third of the cash in transit in the UK, is engaging in a major pilot program with the U.S. military (Defense Logistics Agency) which is fighting counterfeit microchips, has contracted with a Mexican manufacturer to authenticate police uniforms, and counts many more such initiatives.

The Law Enforcement IP Crime conference has played a critical role in past years in coordinating international police efforts against counterfeiting and illicit trade. The various security agencies have made clear in past meetings that counterfeiting is a thriving and integral part of illicit global trade, which includes human slavery, arms traffic, and drug running. In past conferences, trans-national trends have been spotted that are now well known. In 2009, for example, it was noted that Colombian drug organizations had begun leaving the illegal narcotics business to move, instead, into counterfeiting. (Judge Ronald Lew (Sr. US District Court Judge – Central California)).

Brian Monks, of Underwriters Laboratories (UL) commented:

“We are very pleased to have APDN as a sponsor at our Madrid IP Crime Conference. UL is always looking for innovative technologies to help identify authentic products and APDN’s DNA marking solution is a leading edge tool for law enforcement and brand protection to help accomplish this goal.”

Dr. James A. Hayward, Ph.D, President and CEO of Applied DNA Sciences states:

“The Law Enforcement IP Crime Conferences have shown the urgency of adopting strong and reliable technologies against counterfeiting, such as DNA authentication programs. We are certain that a bright spotlight will be trained on the problem this September.”

About APDN

APDN sells patented DNA security solutions to protect products, brands and intellectual property from counterfeiting and diversion. SigNature DNA is a botanical mark used to authenticate products in a unique manner that essentially cannot be copied, and provide a forensic chain of evidence that can be used to prosecute perpetrators. To learn more, go to where APDN routinely posts all press releases.

The statements made by APDN may be forward-looking in nature and are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Forward-looking statements describe APDN’s future plans, projections, strategies and expectations, and are based on assumptions and involve a number of risks and uncertainties, many of which are beyond the control of APDN. Actual results could differ materially from those projected due to our short operating history, limited financial resources, limited market acceptance, market competition and various other factors detailed from time to time in APDN’s SEC reports and filings, including our Annual Report on Form 10-K, filed on December 15, 2010 and our subsequent quarterly reports on Form 10-Q. APDN undertakes no obligation to update publicly any forward-looking statements to reflect new information, events or circumstances after the date hereof to reflect the occurrence of unanticipated events.


To view this StockGuru Spotlight, please visit:

To get free alerts on this and other similar stocks, please register here:

What is the StockGuru Spotlight?

Many companies covered in The StockGuru Spotlight have positive increases in both volume and share price. While this is not true in all cases, StockGuru strives to cover companies in The StockGuru Spotlight that are worth of our readers’ attention.

StockGuru looks for potential break-out candidates in The StockGuru Spotlight.  Many of these companies have had recent news and appear to be getting the attention of investors. StockGuru does not typically feature companies in The StockGuru Spotlight that are compensating StockGuru for this coverage.  There are times when StockGuru covers a stock in The StockGuru Spotlight that had previously compensated Stockguru. Where that is the case, a proper disclosure is included below.   StockGuru and its partners, employees and writers never hold shares, short positions, warrants or any other current position in a stock featured in The StockGuru Spotlight.

To feature a company in The StockGuru Spotlight please contact the Publisher at  If our reader is a key person for a publicly traded company, StockGuru can consider that company for either a StockGuru Spotlight or a StockGuru Profile.  Please contact the StockGuru Publisher John Pentony at this email address: (“SG”) provides its members with the latest news, press releases, and trade alerts for all the companies highlighted on the site SG utilizes information believed to be reliable herein prepared all material. The information contained herein is not guaranteed by SG to be accurate, and should not be considered to be all-inclusive. The owner, publisher, editor and their associates are not responsible for errors and omissions.  SG encourages readers and investors to supplement the information in these reports with independent research and other professional advice. All information on featured companies is provided by the companies profiled, or is available from public sources and SG makes no representations, warranties or guarantees as to the accuracy or completeness of the disclosure by the profiled companies or the information contained herein. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. SG is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein.

This release contains “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. “Forward-looking statements” describe future expectations, plans, results, or strategies and are generally preceded by words such as “may”, “future”, “plan” or “planned”, “will” or “should”, “expected”, “anticipates”, “draft”, “eventually” or “projected”. You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a company’s annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission. You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and SG undertakes no obligation to update such statements. StockGuru is occasionally compensated for coverage.  When this is the case, SG clearly indicates this with a disclosure of all compensation received in the past and present.  Additionally SG also discloses any anticipated compensation in the future.  Compensation is typically in cash.  Sometimes a company pays SG in restricted shares. Pentony Enterprise and its associated companies does not take free trading shares for any reason at anytime. StockGuru is not a registered investment adviser or a broker-dealer. StockGuru makes no recommendation that the purchase of securities of companies profiled in this web site is suitable or advisable for any person, or that an investment in such securities will be profitable. In general, given the nature of the companies profiled and the lack of an active trading market for their securities, investing in such securities is highly speculative and carries a high degree of risk.

John Pentony, Publisher,

Tel: +1 469 252 3031